ABIOMED

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Align Technology

Broadcom

Domino's Pizza

DexCom

Exact Sciences

Jazz Pharmaceuticals

MarketAxess Holdings

Netflix

United Rentals

These ten growth stocks saw the highest percentage growth over the last decade, and some remain unknown to investors despite huge increases.

10 Best-Performing Growth Stocks of the 2010s

NVIDIA

Regeneron Pharmaceuticals

TransDigm

Take-Two Interactive Software

Ulta Beauty

As 2019 comes to a close, a new decade will be upon us. The incredible bull market will also be in its eleventh year since the v-bottom marked in March of 2009.

10 Large Cap Stocks Up 1,000% to 4,000% Over the Last Decade

Shares are trading on the cheap, but are they too risky to touch?

Is Abiomed a Bad-News Buy Right Now?

Macy's

Occidental Petroleum

Macy's, 3M, Occidental and Abiomed are down sharply in 2019, and tax loss selling may send them plunging yet more.

4 Big Name Stocks To Weigh Selling Now Before Losses Widen

Aurora Cannabis

Gulfport Energy Corp

A variety of bad news held back these stocks.

Why Aurora Cannabis, Abiomed, and Gulfport Energy Slumped Today

Shares slump after a pair of clinical studies raises new questions about the safety and cost effectiveness of Abiomed's family of heart pumps. Here are the must-know details.

Why Abiomed Stock Is Falling Today

Edwards Lifesciences

QuidelOrtho Corp

Abiomed, DexCom, Quidel, Other Medical Equipment Stock Buys

Baidu

ABMD, ULTA and BIDU have all fallen out of favor. But each of these growth stocks to buy still has what it takes to make a big-time comeback.

3 Former Growth Stocks to Consider Buying Again

Abiomed, Inc. (ABMD) CEO Mike Minogue on Q2 2020 Results- Earnings Call Transcript

Investors liked the medical device maker's Q2 results.

Why Abiomed Stock Is Jumping Today

Impella's solid show in Japan drives ABIOMED's (ABMD) fiscal second-quarter results.

ABIOMED (ABMD) Earnings Beat, Revenues Miss Estimates in Q2

Abiomed (ABMD) delivered earnings and revenue surprises of 10.75% and -0.65%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Abiomed (ABMD) Q2 Earnings Top Estimates

Abbott Labs

IDEXX Laboratories

Integer Holdings

Teleflex

Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.

Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

Beyond Meat

Texas Instruments

On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes RingCentral Inc (NYSE: RNG) very much, but he understands this is not a market for the stock.

Cramer Advises His Viewers On Beyond Meat, Texas Instruments And More

Exelixis

Five Below

Parsley Energy

Planet Fitness

Pinnacle Financial Partners

XPO Logistics

These 7 growth stocks remain positioned for significant future increases, and could bring huge returns to new investors for years to come.

7 Under-The-Radar Growth Stocks That Could Benefit New Investors

Abiomed's (ABMD) flagship Impella heart pump line is a major growth driver.

Abiomed's (ABMD) Impella 5.5 With SmartAssist Gets FDA Nod

Healthcare Services Group

Livongo Health Inc

Looking for safety in uncertain times? These three healthcare stocks might be a perfect fit.

3 Top Healthcare Stocks to Buy in September

The maker of temporary heart pumps lowered its full-year revenue guidance.

Why Abiomed Stock Plunged 31% in August

Abiomed is a stellar company growing at a rapid pace.

Abiomed Should Be Trading At Double Its Current Valuation

Shockwave Medical

Vertex Pharmaceuticals

These healthcare winners have such strong competitive advantages that their theme song could be MC Hammer's "U Can't Touch This."

3 Healthcare Stocks That Have a Killer Advantage

Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock?

Why Is Abiomed (ABMD) Down 5.8% Since Last Earnings Report?

COO of Abiomed Inc (30-Year Financial, Insider Trades) David M Weber (insider trades) sold 8,095 shares of ABMD on 08/05/2019 at an average price of $206.26 a share.

Abiomed Inc (ABMD) COO David M Weber Sold $1.7 million of Shares

Abiomed is the clear leader in heart pumps.

Pullback Way Overdone, Buy Abiomed

Intuitive Surgical

These medical device stocks appear to have what it takes to be long-term winners.

5 Top Medical Device Stocks to Buy Now

The medical device maker dials back on its growth projections after another tough quarter.

Abiomed Is Still in the Recovery Ward

News for ABIOMED Stock (ABMD)